Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model.
Intra-arterial (IA) delivery of mesenchymal stem cells (MSCs) for acute ischemic stroke is attractive for clinical translation. However, studies using rat model of stroke have demonstrated that IA MSCs delivery can decrease middle cerebral artery (MCA) flow, which may limit its clinical translation....
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/aa4888015b4a4ff6b110e9e41afb9e26 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:aa4888015b4a4ff6b110e9e41afb9e26 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:aa4888015b4a4ff6b110e9e41afb9e262021-11-18T08:20:16ZEfficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model.1932-620310.1371/journal.pone.0093735https://doaj.org/article/aa4888015b4a4ff6b110e9e41afb9e262014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24807059/?tool=EBIhttps://doaj.org/toc/1932-6203Intra-arterial (IA) delivery of mesenchymal stem cells (MSCs) for acute ischemic stroke is attractive for clinical translation. However, studies using rat model of stroke have demonstrated that IA MSCs delivery can decrease middle cerebral artery (MCA) flow, which may limit its clinical translation. The goal of this study is to identify a dose of IA MSCs (maximum tolerated dose; MTD) that does not compromise MCA flow and evaluate its efficacy and optimal timing in a rat model of reversible middle cerebral artery occlusion (rMCAo). We sought to determine if there is a difference in efficacy of acute (1 h) versus sub-acute (24 h) IA MSCs treatment after rMCAo. Adult female Sprague-Dawley rats underwent rMCAo (90 min) and an hour later a single dose of MSCs (at de-escalating doses 1 × 10(6), 5 × 10(5), 2 × 10(5), 1 × 10(5) and 5 × 10(4)) was given using IA route. MSCs were suspended in phosphate buffered saline (PBS) and PBS alone was used for control experiments. We measured the percent change in mean laser Doppler flow signal over the ipsilateral MCA in de-escalating doses groups to determine MTD. The results demonstrated that the lowering of IA MSC dose to 1 × 10(5) and below did not compromise MCA flow and hence an IA MSC dose of 1 × 10(5) considered as MTD. Subsequently, 1 h and 24 h after rMCAo, rats were treated with IA MSCs or PBS. The 24 h delivery of IA MSCs significantly improved neurodeficit score and reduced the mean infarct volume at one month as compared to control, but not the 1 h delivery. Overall, this study suggests that the IA delivery of MSCs can be performed safely and efficaciously at the MTD of 1 × 10(5) delivered at 24 hours in rodent model of stroke.Dileep R YavagalBaowan LinAmi P RavalPhilip S GarzaChuanhui DongWeizhao ZhaoErika B RangelIan McNieceTatjana RundekRalph L SaccoMiguel Perez-PinzonJoshua M HarePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 5, p e93735 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Dileep R Yavagal Baowan Lin Ami P Raval Philip S Garza Chuanhui Dong Weizhao Zhao Erika B Rangel Ian McNiece Tatjana Rundek Ralph L Sacco Miguel Perez-Pinzon Joshua M Hare Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. |
| description |
Intra-arterial (IA) delivery of mesenchymal stem cells (MSCs) for acute ischemic stroke is attractive for clinical translation. However, studies using rat model of stroke have demonstrated that IA MSCs delivery can decrease middle cerebral artery (MCA) flow, which may limit its clinical translation. The goal of this study is to identify a dose of IA MSCs (maximum tolerated dose; MTD) that does not compromise MCA flow and evaluate its efficacy and optimal timing in a rat model of reversible middle cerebral artery occlusion (rMCAo). We sought to determine if there is a difference in efficacy of acute (1 h) versus sub-acute (24 h) IA MSCs treatment after rMCAo. Adult female Sprague-Dawley rats underwent rMCAo (90 min) and an hour later a single dose of MSCs (at de-escalating doses 1 × 10(6), 5 × 10(5), 2 × 10(5), 1 × 10(5) and 5 × 10(4)) was given using IA route. MSCs were suspended in phosphate buffered saline (PBS) and PBS alone was used for control experiments. We measured the percent change in mean laser Doppler flow signal over the ipsilateral MCA in de-escalating doses groups to determine MTD. The results demonstrated that the lowering of IA MSC dose to 1 × 10(5) and below did not compromise MCA flow and hence an IA MSC dose of 1 × 10(5) considered as MTD. Subsequently, 1 h and 24 h after rMCAo, rats were treated with IA MSCs or PBS. The 24 h delivery of IA MSCs significantly improved neurodeficit score and reduced the mean infarct volume at one month as compared to control, but not the 1 h delivery. Overall, this study suggests that the IA delivery of MSCs can be performed safely and efficaciously at the MTD of 1 × 10(5) delivered at 24 hours in rodent model of stroke. |
| format |
article |
| author |
Dileep R Yavagal Baowan Lin Ami P Raval Philip S Garza Chuanhui Dong Weizhao Zhao Erika B Rangel Ian McNiece Tatjana Rundek Ralph L Sacco Miguel Perez-Pinzon Joshua M Hare |
| author_facet |
Dileep R Yavagal Baowan Lin Ami P Raval Philip S Garza Chuanhui Dong Weizhao Zhao Erika B Rangel Ian McNiece Tatjana Rundek Ralph L Sacco Miguel Perez-Pinzon Joshua M Hare |
| author_sort |
Dileep R Yavagal |
| title |
Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. |
| title_short |
Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. |
| title_full |
Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. |
| title_fullStr |
Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. |
| title_full_unstemmed |
Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. |
| title_sort |
efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/aa4888015b4a4ff6b110e9e41afb9e26 |
| work_keys_str_mv |
AT dileepryavagal efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT baowanlin efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT amipraval efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT philipsgarza efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT chuanhuidong efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT weizhaozhao efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT erikabrangel efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT ianmcniece efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT tatjanarundek efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT ralphlsacco efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT miguelperezpinzon efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel AT joshuamhare efficacyanddosedependentsafetyofintraarterialdeliveryofmesenchymalstemcellsinarodentstrokemodel |
| _version_ |
1718421942395994112 |